EDUARDO LUIS
ANGUITA MANDLY
Profesor titular de universidad
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublications en collaboration avec des chercheurs de Hospital de la Santa Creu i Sant Pau (5)
2021
-
Engraftment characterization of risk-stratified AML in NSGS mice
Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854
2020
-
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo
Journal for immunotherapy of cancer, Vol. 8, Núm. 1
2019
-
A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia
Haematologica, Vol. 104, Núm. 2, pp. 288-296
-
Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis
Haematologica, Vol. 104, Núm. 2, pp. e54-e58
2017
-
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes
Stem Cell Reports, Vol. 8, Núm. 6, pp. 1573-1586